Mti-31
N-methyl-3-[2-[(3S)-3-methylmorpholin-4-yl]-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrido[2,3-d]pyrimidin-7-yl]benzamide
Molecular Identity
Mti-31
N-methyl-3-[2-[(3S)-3-methylmorpholin-4-yl]-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrido[2,3-d]pyrimidin-7-yl]benzamide
PubChem CID: 118591386
2D Structure
Properties
C26H30N6O3
Molecular Formula
474.60
Molecular Weight
g/mol
474.2379
Exact Mass
Da
3
XLogP
Drug-like (Lipinski: < 5)
92.7
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
8
H-Bond Acceptors
745
Complexity
SMILES
Canonical SMILES
SMILES: CC1COCCN1C2=NC3=C(C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)C(=N2)N5C6CCC5COC6Isomeric SMILES
SMILES: C[C@H]1COCCN1C2=NC3=C(C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)C(=N2)N5C6CCC5COC6Synonyms(20)
MTI-31UNII-RM15YYQ1CIMtorc 1/2 inhibitor LXI-15029Benzamide, N-methyl-3-(2-((3S)-3-methyl-4-morpholinyl)-4-(3-oxa-8-azabicyclo(3.2.1)oct-8-yl)pyrido(2,3-d)pyrimidin-7-yl)-RefChem:159962LXI150291567915-38-1LXI-15029SCC-31RM15YYQ1CIorb1304105CHEMBL4594431SCHEMBL17354025SCHEMBL29638190SCHEMBL29921552
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Mti-31
Loading drug network...